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1. Introduction 
Septic shock is a life-threatening clinical syndrome caused by decreased tissue perfusion 
and oxygen delivery, as a result of severe infection and sepsis. The insertion of bacteria or 
viruses into the blood stream produces a condition called bacteremia or viremia. Sepsis is 
the systemic inflammatory response due to bacteremia. When sepsis worsen to the point 
where blood pressure cannot be maintained with intravenous fluid alone, then the condition 
is called septic shock and may be accompanied with multiple organ dysfunction (liver, 
kidney, heart, brain). The mortality rate remains high, range between 25 and 50%1. Septic 
shock is the first cause of deaths in intensive care units patients2.  
1.1 Causes of septic shock 
Most episodes of septic shock are caused by gram negative and gram positive organisms. 
Bacteremia is not necessary to develop sepsis, since patients with septic shock have a 
positive blood culture only in 40% to 70% of the cases3. A number of organisms may 
produce exotoxins or endotoxins that also initiate a systemic response. Gram negative 
bacteria contain endotoxin, a complex lipopolysaccharide, in the cell membrane. Lysis of 
them leads to the release of endotoxin. Some gram positive organisms produce also an 
exotoxin and “toxic shock syndrome” toxin; their release produces a similar response to 
lipopolysaccharides. Most cases of septic shock (approximately 70%) are caused by 
endotoxin-producing Gram negative bacteria. However, 5% to 10% have a fungal cause, and 
15% to 20% are polymicrobial4. In emergency patients and the increased use of arterial and 
venous catheters, Gram positive cocci are implicated, as well.  
Invasion of the microorganism into soft tissue leads in a complex cascade of events 
involving monocyte, macrophage and neutrophil recognition, activation, and initial release 
of inflammatory mediators. This constitutes a hyper-inflammatory state5,6. The release of 
inflammatory cytokines, chemokines, prostanoids, reactive oxygen, and nitrogen species 
leads to endothelial dysfunction and increased vascular permeability, myocardial 
suppression, and activation of the coagulation cascade. Patient’s survival correlates with the 
recovery of the inflammatory responses7. 
The response to a microorganism depends on its virulence, size of the inoculum, co-morbid 
conditions, age, nutritional status and genetic polymorphisms in immune related genes6. 
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Early recognition, prompt diagnostic workup and immediate initiation of therapy improve 
the prognosis of patients with septic shock syndrome. 
Shock associated with sepsis can be caused by a variety of pathologic phenomena. It needs 
to be recalled that other mechanisms can be responsible. Hypovolemic shock can occur 
under conditions of sepsis due to massive fluid accumulation at the local site of infection. 
Other non-immunogenic causes of shock during sepsis that require consideration are 
cardiogenic causes. 
1.2 Differential diagnosis of septic shock 
Septic shock must be differentiated between systemic inflammatory response syndrome, 
sepsis, severe sepsis, hypotension, and multiple organ dysfunction syndrome as definitions 
were set in 1991 by the American College of Chest Physicians and the Society of Critical 
Care Medicine8,9.  
The phrase “systemic inflammatory response syndrome” describes the inflammatory 
process that can be generated by infection or by noninfectious causes such as pancreatitis, 
burns, and trauma. The response is manifested by two or more of the following conditions: 
1) temperature greater than 38oC or less than 36oC, 2) heart rate greater than 90 beats per 
minute, 3) respiratory rate greater than 20 breaths per minute or arterial carbon dioxide 
pressure less than 32 mmHg, and 4) white blood cell count greater than 12000/mm3 or less 
than 4000/ mm3 or greater than 10% band forms. Sepsis as was described above is systemic 
inflammatory response syndrome due to infection. Severe sepsis is sepsis associated with 
organ dysfunction, hypoperfusion, or hypotension. Hypotension is defined as a systolic 
blood pressure <90 mmHg or a reduction of greater than or equal to 40 mmHg from 
baseline. Finally multiple organ dysfunction syndrome is the presence of altered organ 
function in an acutely ill patient such that homeostasis cannot be maintained without 
intervention. 
2. Incidence of sepsis and septic shock 
An accurate estimation of the incidence of sepsis and septic shock is hampered by the lack of 
reliable case definition. Inconsistent application of sepsis definition criteria contributes to 
confusion and variability in the literature10. The Centers for Disease Control estimated an 
incidence of 73.6 per 100,000 population in 1979, rising to 175.9 per 100,000 in 198911. The 
rates have been probably increased because of more immuno-suppressed patients, new 
immunomodulating therapy, increased use of invasive devices (e.g., central venous 
catheters), and an increase in antibiotic resistance5,6,12. A review of discharge data on 
approximately 750 million hospitalizations in U.S.A. over a 22-year period (1979-2000) 
identified 10,319,418 cases of sepsis5. Sepsis was more common among men than among 
women (mean annual relative risk, 1.28; 95% CI: 1.24-1.32) and among non-white persons 
(mean annual relative risk 1.90; 95%CI: 1.81-2.00)5. However, these data is hampered due to 
the broad definition of sepsis and may be overestimate the accurate incidence of sepsis and 
septic shock since include all the ICD-9-CM* codes for definition of sepsis (038 [septicemia], 
020.0 [septicemic], 790.7 [bacteremia], 117.9 [disseminated fungal infection], 112.5 
[disseminated candida infection], and 112.81 [disseminated fungal endocarditis]. Organ 
                                                 
* ICD-9 CM denotes International Classification of Diseases, Ninth Revision, Clinical Modification 
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failure was defined by a combination of ICD-9 CM and CPT† codes. In general, there are few 
population-based prospective cohort studies that allow us to accurately delineate the 
incidence of sepsis and septic shock.  
The mortality rate from sepsis is approximately 40% in adults, and 25% in children. It is 
significantly greater when sepsis left untreated for more than seven days13. 
3. Sepsis and septic shock during pregnancy 
3.1 Prevalence and mortality rate in pregnancy 
Septic shock in obstetric patients is rare because pregnant women are younger and have less 
co-morbid conditions. The common area of infection is the pelvis and the responsible 
microorganisms are sensitive in most of the broad spectrum antibiotics. Specific data on 
serious acute maternal morbidity due to sepsis are scarce, partly because of lack of a 
uniform definition of sepsis, but reported incidences in western countries vary from 0.1 to 
0.6 per 1000 deliveries14. Although the incidence of septic shock in obstetric patients is low 
and has been decreased throughout the years it remains a significant factor of maternal 
morbidity and mortality related with pregnancy. Sepsis continues to account for 
approximately 7.6% of maternal deaths in the United States15.  
WHO defines puerperal sepsis as infection of the genital tract occurring at any time between 
the onset of the rupture of membranes or labour and the 42nd day postpartum in which 
fever and one or more of the following are present: pelvic pain, abnormal vaginal discharge, 
abnormal odour of discharge, and delay in the rate of reduction of size of the uterus16. It is 
estimated that puerperal sepsis causes at least 75,000 maternal deaths every year, mostly in 
low-income countries17. Studies from high-income countries report incidence of maternal 
morbidity due to sepsis of 0.1-0.6 per 1000 deliveries17.  
3.2 Are pregnant women more prone to infections and sepsis? 
The concept that pregnancy is associated with immune suppression has created a myth of 
pregnancy as a state of immunological weakness and therefore, of increased susceptibility 
to infectious disease. Pregnancy represents the most important period for the 
conservation of the species, thus, it is fundamental to strengthen all the means to protect 
the mother and the fetus. The maternal immune system is characterized by a reinforced 
network of recognition, communication, trafficking and repair, in order to maintain the 
well-being of the mother and the fetus18. The fetus provides a developing active immune 
system that will modify the way the mother responds to antigens18. Therefore, it is 
appropriate to refer to pregnancy as a unique immune condition that is modulated but 
not suppressed19.  
Pregnancy has three distinct immunological phases that are characterized by distinct 
biological processes20,21. The first stage of implantation is a pro-inflammatory condition that 
the blastocyst has to invade the endometrial tissue in order to implant; the endometrium has 
to be replaced by trophoblast and new vessels in order to secure an adequate placental-fetal 
blood supply22. The placentation phase of pregnancy characterized by an anti-inflammatory 
state, where, the mother, the placenta, and the fetus are symbiotic18. Finally, during the last 
immunological phase, the mother needs to deliver the baby, and this can only be achieved 
through renewed inflammation. Parturition is characterized by an influx of immune cells 
                                                 
† CPT Current Procedural Terminology 
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into the myometrium in order to promote recrudescense of an inflammatory process23,24. A 
recent longitudinal study during uncomplicated pregnancies revealed a general trend 
toward enhanced counter-regulatory cytokine expression (IL-10), and an overall decrease of 
pro-inflammatory (Th1; TNFa, IL-1β, and IL-6) cytokines expression25. Pregnancy itself does 
not impair the woman’s immunological system and other risk factors have to be 
implemented to develop infections in pregnant women. 
3.3 Risk factors and routes of infection in pregnancy  
Sepsis during pregnancy usually is the result of invasion of the uterine cavity with bacterial 
pathogens. Although transplacental spread of infection can occur in women with bacteremia 
that doesn’t correlate with pregnancy, the most common route is an ascending infection 
from bacteria colonize the vagina and/or the cervix15. Pelvic infections in pregnant women 
have their microbiologic origin in one of three sources: the endogenous vaginal microflora, 
the intestinal microflora, and sexual transmission26. The infection occurs via migration of  
the organisms from the vagina through the endocervix into the uterus. Some organisms may 
traverse the columnar epithelium, as is the case with infection caused by Neisseria 
gonorrhoeae and Chlamydia trachomatis26. Bacteria such as Streptococcus agalactiae  
may gain entrance to the uterus and fallopian tubes via the lymphatics26. A third route  
of migration is by ascending into the pregnant uterus and colonizing amniotic fluid.  
Then bacteria are able to reproduce and reach numbers in excess of 105 per milliliter of 
amniotic fluid27.  
Risk factors for the development of maternal sepsis include home birth in unhygienic 
conditions, low socioeconomic status, poor nutrition, primiparity, anaemia, prolonged 
rupture of membranes, prolonged labour, multiple vaginal examinations in labour (more 
than five), caesarean section, multiple pregnancy, artificial reproductive techniques, 
overweight and obstetrical manoeuvres14,28. 
3.4 Reasons for infection and sepsis during pregnancy 
Physiologic changes in the lower genital tract, such as a decreased in pH and increased 
glycogen in the vaginal epithelium, place the pregnant woman at risk for intra-amniotic 
infection. Pregnant women, with the enlargement of uterus, especially during the 3rd 
trimester, may cause stricture or even obstruction of the ureter, predisposing for the 
development of pyelonephritis. In addition, normal pregnancy is characterized by 
numerous changes in the hemostatic system, creating the hypercoagulable state which 
increases the risk of venous thromboembolic event occurrence29. An elevated leukocyte 
count, associated with a slightly increased c-reacting protein, and increased heart rate of 15-
20 bpm, may mask early signs and symptoms of infection favouring the dissemination of 
bacteria into the blood-stream. Conditions that predispose pregnant women to septic shock 
syndrome can be intra-amniotic infection, septic abortion, septic pelvis thrombophlebitis, 
postpartum endometritis, pyelonephritis, wound infection, necrotizing fasciitis, appendiceal 
abscess, cholecystitis and invasive procedures like amniocentesis, chorionic villus sampling, 
and cervical cerclage placement. 
Moreover, septic shock in pregnancy can be due to reasons that don’t correlate with 
pregnancy. Non-obstetric septic shock can be caused by pneumonia and peritonitis with 
origin in colon, gastro-duodenum, post-duodenal small bowel, biliary tract and appendix. 
(Table 1) 
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Obstetrics Non-obstetrics 
Intra-amniotic infections Pyelonephritis 
Chorioamnionitis Septic pelvic thrombophlebitis 
Septic abortion Abscess of the appendix 
Invasive procedures for prenatal diagnosis 
(amniocentesis, chorionic villous sampling) 
Cholecystitis 
Cervical cerclage placement Pneumonia 
Post-partum endometritis Peritonitis (colon, small bowel, gastro-
duodenum, biliary tract) 
Wound infection  
Necrotizing fasciitis  
Table 1. Conditions that predispose women to sepsis and septic shock syndrome during 
pregnancy 
3.5 Chorioamnionitis and intra-amniotic infection 
Intra-amniotic infections before 1970 was a major cause of maternal mortality because of 
patient delays in seeking treatment, unavailability of intensive care, and the absence of 
broad spectrum antibiotics30. Nowadays, the association of intraamniotic infections with 
septic shock, coagulopathy, and adult respiratory syndrome (ARDS) is rare, accounting for 
less than 1% in cases of intraamniotic infections30,31.  
It is important to note that intraamniotic infections in pregnancy usually are polymicrobial 
in nature. The most common route is an ascending infection from one or more of the 
endogenous flora of the cervix or vagina. The most frequent causative pathogens are 
Aerobic Bacteria (group B β-hemolitic Streptoccocus, Enteroccocus, other Streptoccocus species, 
Escherichia coli, Hemophilus Influenzae, Pseudomonas species, Staphylococcus aureus, Klebsiella-
Enterobacter species, Proteus species), Anaerobic Bacteria (Peptococcus species, 
Peptostreptococcus species, Clostridium species, Bacteroides species, Fusobacterium species) and 
other (Gardnerella vaginalis, Mycoplasme Hominis, Ureaplasma Urealyticum, Chlamydia 
Trachomatis) (Table 2). It is important to note when group B β-Streptococcus or Escherichia 
coli are the causative pathogens, the incidence of bacteremia is higher (18% and 15%, 
respectively)30.  
As a consequence of intraamniotic infection is the spontaneous rupture of membranes by 
weakening the membranes, either by a direct effect of microorganisms on the membranes or 
indirectly by activation of the host defense mechanisms. However, there is not an absolute 
and exclusive correlation between intra-amniotic infection and spontaneous rupture of 
membranes. Rupture of membranes predispose but not secure the development of intra-
amniotic infection. This is especially true, after the administration of broad spectrum 
antibiotics.  
An estimated 5-10% of women with intraamniotic infections have bacteremia30. Almost half 
of the patients with bacteremia will demonstrate signs and symptoms of sepsis32. 
Approximately 40% of patients with sepsis have the condition progress to septic shock33. 
Progression from intraamniotic infections to bacteremia, sepsis, and septic shock can occur 
in a few days or several hours. Typical clinical manifestations of septic shock appeared 
additionally to the signs of intraamniotic infections and include altered mental status, 
peripheral vasodilation, tachypnea, tachycardia, temperature instability, hypotension, 
increased cardiac output, and decreased peripheral resistance31,34. If the condition is not 
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promptly identified and aggressively treated, progressive symptoms of peripheral 
vasoconstriction, oliguria, cyanosis, ARDS, disseminated intravascular coagulation, 
decreased cardiac output, and decreased peripheral resistance may occur34. 
 
Aerobic bacteria 
 Group B β-hemolytic Streptococcus 
 Streptococcus species 
 Enterococcus 
 Escherichia coli 
 Haemophilus influenza 
 Staphylococcus aureus 
 Pseudomonas species 
 Klebsiella species 
 Proteus species 
 Enterobacter species 
Anaerobic bacteria 
 Peptococcus species 
 Peptostreptococcus species 
 Clostridium species 
 Bacteroides species 
 Fusobacterium species 
Other 
 Gardnerella vaginalis 
 Mycoplasma Hominis 
 Ureaplasma urealyticum 
 Chlamydia trachomatis 
Table 2. Common causative pathogens of ascending infection in pregnant women. 
Chorioamnionitis is an acute inflammation of the membranes and chorion of the placenta. 
Typically is the result of ascending polymicrobial bacterial infection in the setting of 
membrane rupture. It can also occurs with intact membranes after infection with Ureaplasma 
species and Mycoplasma hominis, found in the lower genital tract35. Only rarely is 
hematogenous spread implicated in chorioamnionitis, as occurs with Listeria 
monocytogenes36.Overall, 1-4% of all births in the U.S.A. are complicated by 
chorioamnionitis36; however, the frequency varies markedly by diagnostic criteria, specific 
risk factors, and gestational age37,38. The key clinical findings include fever, uterine fundal 
tenderness, maternal tachycardia (>100/min), fetal tachycardia (>160/min), and purulent or 
foul amniotic fluid36,39. The most common organisms isolated in up to 47% and 30% 
respectively, in cases of culture confirmed chorioamnionitis are Ureaplasma urealyticum and 
Mycoplasma hominis40,41. 
Chrorioamnionitis leads to a 2 to 3-fold increased risk for caesarean delivery and to 2 to 4-
fold increase in endomyometritis, would infection, pelvic abscess, bacteremia, and post-
partum hemorrhage42-44. Women with chorioamnionitis in 10% have positive blood cultures 
(bacteremia)36. Fortunately, septic shock, disseminated intravascular coagulation, adult 
respiratory distress syndrome, and maternal death are only rarely encountered44,45. In 
contrast, fetal exposure to infection may lead to fetal death, neonatal sepsis, and septic 
shock. In one study, neonatal pneumonia, sepsis, and perinatal death occurred respectively, 
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in 4%, 8%, and 2% of term deliveries associated with chorioamnionitis46. The frequency of 
neonatal sepsis is reduced by 80% with intrapartum antibiotic treatment47. 
Prompt initiation of antibiotic therapy is essential to prevent both maternal and fetal 
complications in the setting of clinical chorioamnionitis44. Time-to-delivery after institution 
of antibiotic therapy has been shown to not affect morbidities; therefore caesarean section to 
expedite delivery is not indicated for chorioamnionitis unless there are other obstetric 
indications44,48. 
3.6 Does the mode of delivery affect the incidence of sepsis and septic shock? 
Nowadays, rates of caesarean section (CS) are progressively increasing in many parts of the 
world. There has been an increasing tendency for pregnant women without justifiable 
medical indications for CS to ask for this procedure. Despite the World Health 
Organization’s estimate that CS rates should not be >15%, in the developed world, CS rates 
are already above 30%49,50. Following CS, maternal mortality and morbidity may result from 
a number of infections including endometritis, urinary tract infection and surgical site 
infection, which if deep rather than superficial, increase hospital stay and cost per case51-53. 
The most common infection-related complication following CS is endometritis53. A major 
risk factor for post-CS infection is emergency CS (compared with elective).  
The rate of infection following CS is 1.1–25% compared with 0.2–5.5% following vaginal 
birth54-56. In antepartum patients the most common infection is asymptomatic bacteriuria 
with an incidence estimated at 4-7%. However, with the use of prophylactic antibiotic 
treatment is extremely rare these infections to become sepsis and septic shock, regardless of 
the mode of delivery. Recent evidence suggests that pre-incision broad spectrum antibiotics 
are more effective in preventing post-CS infections than post-clamping of the cord narrow-
range antibiotics, without prejudice to neonatal infectious morbidity57. Prophylactic 
antibiotics can reduce the incidence of endometritis following CS by two thirds to three 
quarters53.  
Data from Europe for the years 2003–2004 showed a range of maternal mortality ratio from 
2/100,000 live births in Sweden, to 29.6/100,000 in Estonia58. Direct maternal mortality 
associated with CS was about 0.06‰59. However, very few women are dying from primary 
infection and sepsis. Haemorrhage is the main cause of death following by 
thromboembolism and preeclampsia. Even though the majority of women are dying during 
puerperium (60%), the infection mostly started during pregnancy or delivery and only in 
rare cases after delivery and subsequently was not correlated with the mode of delivery. 
Collectively, we can suggest that CS affects the incidence of infection and hospitalization of 
women but is not correlated with severe sepsis and septic shock.  
3.7 Amniocentesis, chorionic villous sampling (CVS): Routine procedures  
but invasive? 
Although amniocentesis and CVS are routine procedures in prenatal diagnosis and are 
nowadays performed in most clinics under continuous ultrasonographic vision and aseptic 
conditions, they are invasive procedures carrying potential risks of serious complications for 
both the mother and the fetus. Intrauterine infection is a rare event after invasive prenatal 
diagnostic procedures60. According to data from large studies, the incidence of 
chorioamnionitis is 5 per 1,000 cases after CVS; 3.7 per 1,000 cases after amniocentesis; and 
8.8 per 1000 cases after cordocentesis, compared with 3 per 1,000 cases in non-exposed 
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women61,62. Infection is usually mild to moderate. There are, however, sporadic reports in 
the literature describing cases of post-procedure sepsis with devastating results60. 
Deterioration to septic shock may develop in 0.03% to 0.19% of intra-amniotic infection 
cases63. 
Contamination of the uterine cavity after amniocentesis or CVS may occur through 
ascending infection, direct inoculation of intestinal germs, and rarely, after use of deficiently 
sterilized equipment and direct spread of the infection from the vagina to the blood stream, 
by-passing the uterus64. Direct inoculation of vaginal or cervical pathogens into the uterine 
cavity may underlie the development of sepsis after trans-cervical CVS65-67. The reported 
rate of transient post-procedure bacteremia is 4.1% for transcervical CVS and nearly zero for 
transabdominal procedure64,68. Inoculation of intestinal germs has been implicated in cases 
of sepsis after transabdominal procedures. In such cases, peritoneal signs are expected to 
predominate69. 
Incubation time is usually short, and the onset of symptoms is usually manifested within 24 
hours after the procedure. The onset can be insidious, but the clinical and laboratory 
indicators deteriorate quickly, and the progress can be fulminant60. Clostridium perfrigens, 
together with Escherihia coli, are the most common pathogens encountered in cases of sepsis 
after prenatal diagnosis and they are associated with severe and serious complications. Other 
pathogens isolated from endometrial remnants or blood cultures after amniocentesis or CVS 
include Klebsiella pneumoniae, Enterobacter, Staphylococcus aureus, Serratia rubidaea, Citrobacter, 
Clostridium welchii, group B β-hemolytic streptococcus, and Candida albicans (Table 3). 
Administration of prophylactic antibiosis is not recommended since most retrospective 
studies failed to prove a direct association between needle insertion and maternal or fetal 
complications70-72. Prospective, double-blind studies in this topic are lacking. In cases of 
sepsis, evacuation of the uterine cavity and suction curettage can be performed. In severe 
cases prompt hysterectomy with the dead fetus in situ may be advisable if there is evidence 
of sepsis with hemolysis, multiple organ failure and rapid progress of infection. However, 
the decision to perform hysterectomy is difficult, especially in a case of a young nulliparous 
woman or a woman with an affected child and should be performed only in cases where 
woman’s life is at risk. Although very rare, potentially fatal sepsis can occur after invasive 
prenatal diagnostic procedures. Sepsis can begin with very subtle clinical signs and 
symptoms, but quickly develop complications, which can become irreversible if intervention 
is delayed.   
3.8 Septic abortion 
Septic abortion, an abortion related with infection and complicated by fever, endometritis, 
and parametritis, remains one of the most serious threats to the health of women throughout 
the world85. More than 95% of the septic abortion and septic shock cases are synonymous 
with illegal, criminal or non-medical abortions86. The most important effect of the 
legalization of abortion on public health in the U.S.A. was the almost elimination of deaths 
due to infection from illegal abortion87,88. The mortality rate after septic abortion has been 
decreased dramatically after the introduction of broad spectrum antibiotics. In the U.S.A., is 
0.4 cases per 100,000 legal abortions, whereas, in Europe is 1 case per 100,000 legal 
abortions89,90. Abortion remains a primary cause of maternal death in Third World countries. 
W.H.O. estimates that 25-50% of the 500,000 maternal deaths that occurs every year result 
from illegal abortion91. Abortion-related deaths result primarily from sepsis92. 
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Author Procedure Management Complications Outcome Culture 
Wurster et al.63 Amniocentesis Hysterectomy NA Recovery C. welchii 
Fray et al.73 Amniocentesis Hysterectomy NA Recovery Clostridium+S. 
rubidaea+Citrobacte
r 
Muggah et al.74 CVS Hysterectomy DIC-ARDS Recovery E. coli 
Hovav et al.75 Amniocentesis D&C ARDS-ARF Recovery C. perfrigens+E.coli 
Ayadi et al.76 Amniocentesis D&C DIC-ARDS-
cardiac arrest 
Deceased C. perfrigens+E.coli 
Thabet et al.77 Amniocentesis Expulsion DIC-MOF Recovery Klebsiella+Enteroba
cter 
Winer et al. (2 
cases)78 
Amniocentesis Induction of 
abortion 
DIC-
cardiorespirator
y arrest 
Recovery E.coli 
Lau Tze Kin et 
al.79 
Amniocentesis Abortion+antibi
otic 
DIC-hypoxemia Recovery E. coli 
Paz et al.80 CVS Antibiotic -  Candida albicans 
Hamanishi et al.69 Amniocentesis Abortion+hyster
ectomy 
DIC-MOF Recovery E.coli 
Li Kim Mui et 
al.81 
Cordocentesis Abortion - Recovery C. perfrigens+S. 
aureus 
Plachouras et al.60 Amniocentesis+
Cordocentesis 
Hysterectomy DIC-MOF Recovery C. perfrigens 
Oron et al.64 CVS Antibiotic - Recovery Group B β-
hemolytic 
Streptococcus 
Kye Hun Kim et 
al.82 
Amniocentesis Conservative DIC-AMI Recovery E.coli 
Thorp et al.83 Amniocentesis Conservative DIC Deceased E.coli 
Elchalal et al. (2 
cases)84 
Amniocentesis Antibiotic+D&C DIC-MOF Deceased E.coli 
NA: not available; CVS: chorionic villous sampling; DIC: disseminated intravascular coagulation; 
ARDS: adult respiratory distress syndrome; D&C: dilation and curettage; ARF: acute renal failure; 
MOF: multiple organ failure; AMI: acute myocardial infarction 
Table 3. Case report of sepsis after invasive prenatal diagnosis 
The risk of sepsis from abortion rises from the first trimester of pregnancy to the second89. In 
the first trimester, abortion is readily performed by vacuum curettage, usually in an 
outpatient setting. Incomplete abortions produced by incompetent physicians represent 
another risk factor. Insertion of rigid foreign objects into the uterus or cervix increases the 
risk of perforation and infection93. Intrauterine instillation of soap solution containing cresol 
and phenol has been abandoned, due to the risk of uterine necrosis, renal failure, toxicity to 
the central nervous system, cardiac depression, and respiratory arrest94.  
The bacteria associated with septic abortion are usually polymicrobial, derived from the 
normal flora of the vagina and endocervix, with the important addition of sexually 
transmitted pathogens95,96. Septic shock complicates approximately 0.7% of septic abortions 
and the offending organisms are Gram-negative bacteria (Escherichia coli, Aerobacter 
aerogenes, Proteus mirabilis or vulgaris and Pseudomonas aeruginosa) which produce an 
endotoxin86. However, Gram-positive bacteria (Clostridium welchii or perfrigens, Neisseria 
gonorrhoae, Staphylococcus epidermisis, Streptococcus agalactiae), anaerobic bacteria and 
www.intechopen.com
 
Severe Sepsis and Septic Shock – Understanding a Serious Killer 
 
320 
Chlamydia trachomatis are all possible pathogens86, 97. Because of the variety of bacterial 
agents that can be associated with septic abortion, no-one antibiotic agent is ideal. The 
regimens recommended for outpatient management of pelvic inflammatory disease (PID) 
are appropriate for early post-abortion infection limited to the uterine cavity95.  
The diagnosis of septic abortion must be considered when any woman of reproductive age 
presents with vaginal bleeding, lower abdominal pain, and fever. If the woman has had 
symptoms for several days, a generalized, serious illness may be present. Bacteremia, which 
is more common with septic abortion than with other pelvic infection, may result in septic 
shock and the adult respiratory distress syndrome98. Management of severe sepsis requires 
eradication of the infection and supportive care for the cardiovascular system and other 
involved organ systems. Any tissue remaining from the pregnancy must be evacuated 
without delay as soon as antibiotic therapy and fluid resuscitation have been started. In 
critically ill women with severe sepsis, a hysterectomy will probably be needed. Other 
indications of laparotomy are uterine perforation with a suspected bowel injury, a pelvic 
abscess, and clostridial myometritis98.  
Cervical dilation with laminaria placement has been also associated rarely, with septic 
abortion and septic shock99. Laminarias are sea plant with hydroscopic properties that 
enable their expansion up to five times in diameter over 12-24 hours, thereby gradually 
dilating the cervix. The potential of laminarias to harbor pathogens led some investigators to 
speculate that colonization of laminaria tents may lead to post-abortion infection. However, 
with modern sterilization techniques, the associated infection rates are similar to those 
achieved with standard methods for cervical dilation99. 
Nowadays, medical termination of pregnancy using mifepristone and/or misoprostol 
doesn’t require admission to the hospital or anesthesia and is alternative to surgical 
termination100. The incidence of uterine infection after medical termination of pregnancy is 
very low. However, severe and fatal infections have been reported in certain cases; most of 
them were associated with Clostridium infections and development of toxic shock 
syndrome101-103. Klebsiella pneumoniae has also been reported as the cause of septic shock 
after medical termination of pregnancy with misoprostol-only regimen100. Although a direct 
association of these drugs and septic shock has established, it was postulated that 
mifepristone blocks both progesterone and glucocorticoid receptors and affects the innate 
immune system104. However, most of these severe and occasionally fatal complications are 
the result from inappropriate usage of drugs without any medical monitoring and 
consultation.  
3.9 Non-obstetric causes of septic shock 
Septic shock in the pregnant woman usually results from an infection in the urinary or 
genital tract. Pyelonephritis is the most frequent cause of bacterial shock associated with 
pregnancy105. Enlargement of the uterus during the 2nd and 3rd trimester of pregnancy may 
cause stricture and/or obstruction of the ureters, a condition that predisposes to urinary 
infections and pyelonephritis. Escherichia coli is responsible for most of the cases. Klebsiella 
pneumoniae, Proteus species, and Enterobacter-Citrobacter are less common pathogens.  
All pregnant women should be screened for the presence of bacteriuria at their first prenatal 
visit. Failure to treat bacteriuria during pregnancy may result in as many as 25% of women 
experiencing acute pyelonephritis106. Acute pyelonephritis has an incidence of 
approximately 0.1-1% in pregnancy; most occurs at second trimester107. It is associated with 
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multiple complications, including fetal growth restriction, preterm labour, cerebral palsy 
and septicemia, although the underlying mechanisms are poorly understood108. One 
mechanism could be the alteration in the profile of angiogenic and anti-angiogenic factors 
(increased expression of vascular endothelial growth factor [VEGF], decreased expression of 
PIGF and sVEGFR-2) observed in cases with acute pyelonephritis that resembles the one 
observed in sepsis109. In most reports of acute pyelonephritis the incidence of bacteremia is 
not stated. However, 20% of women with severe pyelonephritis will develop complications 
that include septic shock syndrome or its presumed variants110. These latter include renal 
dysfunction, hemolysis and thrombocytopenia, and pulmonary capillary injury. In another 
series of 55,621 pregnant women with acute pyelonephritis, the incidence of septic shock in 
pregnancy was 3.77%111. The first fatal case of gestational interstitial tubulonephritis and 
chronic pyelitis caused by Escherichia coli has been recently described 112. In the great 
majority of cases, continued fluid and antimicrobial therapy result in a salutary outcome, 
but there is still an occasional maternal morbidity.  
Post-partum endometritis (PE) can also result to septic shock. Patients with PE may show a 
delayed response to antibiotic treatment because of the development of septic pelvic vein 
thrombosis26. In these cases heparin should be administered. Patients who do not respond 
to antibiotics and heparin should be considered to have thrombosis of the vasculature of the 
uterus or an abscess26. Decreased perfusion of the myometrium does not permit adequate 
antibiotic levels to be established in the myometrium and uterine necrosis could be 
observed. In such occasions, hysterectomy should be performed.  
Various other conditions have been reported to predispose the pregnant woman to sepsis 
and septic shock including pelvic abscess, wound infection, necrotizing fasciitis, 
appendiceal abscess, acute cholecystitis, septic pelvic vein thrombosis, pneumonia, 
pancreatitis, and lupus.  
4. Septic shock in gynecologic patients 
In Gynecology, incidence of sepsis have been increased during the last 15 years, presumably 
due to an aging population, an increase in the number of invasive procedures performed, 
and possibly due to a resistance to the current antibiotic treatment appeared in the infecting 
pathogens. Sepsis-related situations in Gynecology can be found, in women using intra 
uterine devices (IUD), after untreated pelvic inflammatory disease (PID), after toxic shock 
syndrome provoked mainly by the use of tampons during menstrual period, and in patients 
with gynecological cancer. The above causes will be discussed explicitly, thereafter. 
4.1 Toxic shock syndrome 
Toxic shock syndrome (TSS), is a rare, life-threatening, multiorgan illness that is caused by 
toxins that circulate in the bloodstream. Development of TSS involves three distinct stages: 
local proliferation of toxin-producing bacteria at the site of infection, production of toxin, 
and exposure of this toxin to the immune system with resultant immune response113,114. 
Toxic shock syndrome was initially identified as a pediatric infection in 1978115. Subsequent 
reports identified an association with tampon use by menstruating women.116-118.  Menstrual 
TSS is more likely in women using highly absorbent tampons, using tampons for more days of 
their cycle, and keeping a single tampon in place for a longer period of time. Over the past two 
decades, the number of cases of menstrual TSS (1 case per 100,000) has steadily declined; this is 
thought to be due to the withdrawal of highly absorbent tampons from the market116. 
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In the most typical form of toxic shock syndrome, the bacteria, most commonly, group A 
Streptococcus, Staphylococcus aureus and Clostridium sordellii produce an enterotoxin that 
transfers into the bloodstream, provoking the overstimulation of the immune system. This, 
in turn, causes the severe symptoms of TSS, such as: fever, rash, myalgias, diarrhea, 
vomiting, headache, sore throat, vaginal discharge, rigors, desquamation (typically of the 
palms and soles), hypotension, and multi-organ failure (involving at least 3 or more organ 
systems116,119,120. The mortality rate of toxic shock syndrome is approximately 5-15%, and 
recurrences have been reported in as many as 30-40% of cases121,122. 
The role of tampons in the pathogenesis of TSS is incompletely understood. Although 
tampons are not a source for toxigenic S.aureus and do not appear to increase the S. aureus 
cell density vaginally, studies have shown that tampons used during menstruation often 
colonized with this pathogen123,124. Vaginal conditions during menses and tampon use, 
contribute to the proliferation of toxin-producing S.aureus. An elevated vaginal temperature 
and neutral pH, both of which occur during menses are enhanced by tampon use, allowing 
bacterial proliferation125. Endometrial blood can serve as a medium for bacterial growth; 
persistence of this blood in the cervical and vaginal canal with tampon use has been also 
shown to increase the proliferation of S.aureus126. In addition, synthetic fibers are thought to 
alter the availability of certain substrates to lactobacilli, a normal vaginal colonist that limits 
the proliferation of S.aureus. The same conditions also aid in the production of TSS Toxin-1. 
Menses and tampon use increase the partial pressure of both oxygen and carbon dioxide, 
which also stimulate toxin production127. In addition, tampons obstruct the flow of 
endometrial blood and may even cause the reflux of blood and bacteria into the uterus. 
Toxic shock syndrome is the typical example of a systemic inflammatory response 
syndrome, with virtually all of the effects derived from immune mediators rather than as a 
direct result of infection. The diagnosis of TSS should be considered in a patient who 
presents with septic shock but without any obvious source of infection. The case fatality 
rates for menstrual-related STSS have declined from 5.5% in 1980 to 1.8% in 1996121,122. 
Organ supportive therapy remains the standard of care with antibiotics used to prevent 
recurrence, although newer immune-based therapies are being developed that may help in 
the treatment of TSS and other inflammatory syndromes in the future. 
4.2 Pelvic inflammatory disease (PID) 
Pelvic inflammatory disease (PID) refers to acute infection of the upper genital tract 
structures in women, involving any or all of the cervix, uterus, fallopian tubes, ovaries and 
surrounding structures. By definition, PID is a community-acquired infection, initiated by a 
sexually transmitted agent, distinguishing it from pelvic infections due to medical 
procedures, pregnancy and other primary abdominal processes. Pelvic inflammatory 
disease in the United States annually accounts for about 2,5 million outpatient visits, 200,000 
hospitalizations and 100,000 surgical procedures128. It is the most frequent gynecologic cause 
for emergency department visits (350,000/year)128,129. 
PID is most frequently caused by bacteria that are transmitted through sexual contact and 
other bodily secretions. Bacteria that cause gonorrhea and additionally the Chlamydia 
trachomatis cause more than half of cases. Many studies suggest that a number of patients 
with PID and other sexually transmitted diseases are often infected with two or more 
infectious agents and commonly these are Chlamydia trachomatis, Neisseria gonorrhoeae and 
Mycoplasma genitalium130. Sexually active adolescent females and women younger than 25 
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years are at greatest risk, although PID can occur at any age. Abdominal pain (usually 
lower) or tenderness, fever, nausea, vomiting, back pain, unusual or heavy vaginal 
discharge, abdominal uterine bleeding, painful urination, painful sexual intercourse are 
some of the symptoms of PID131. 
The vaginal flora of most normal, healthy women includes a variety of potentially 
pathogenic bacteria132. Among these are species of streptococci, staphylococci, 
Enterobacteriaceae (most commonly, Klebsiella spp, Escherichia coli, and Proteus spp), and a 
variety of anaerobes. Compared with the dominant hydrogen peroxide-producing 
Lactobacillus, these organisms are present in low numbers, and ebb and flow under the 
influence of hormonal changes, contraceptive method, sexual activity, and other as yet 
unknown forces. Complete disruption of the vaginal ecosystem can occur, in which 
anaerobic bacteria assume predominance over the desirable strains of lactobacilli133. Then an 
ascending infection occurs causing: cervicitis, endometritis, salpingitis or hydro-, pyo-
salpinx. In tubes and ovaries, salpingo-oophoritis (acute, subacute and chronic) or a tubo-
ovarian abscess may also occur. In the peritoneal cavity spreading of the infection causes 
pelvic and/or generalized peritonitis or a pelvic abscess. Infection may be also spread 
through the uterine wall into broad ligaments to cause pelvic cellulitis (parametritis), a 
broad ligament abscess or septic thrombophlebitis of the ovarian or uterine veins, leading to 
septicemia with few local signs134.  
Bacteremia is an unusual condition and is not correlated with PID. Blood cultures for 
women hospitalized with acute PID showed negative results in 97% of the cases135. The 
results of blood culture are not affect the clinical management of PID and routine specimens 
may not be needed from patients hospitalized for acute PID135. However, if diagnosis and 
treatment are not performed in a timely manner, PID may cause sepsis, septic shock and 
even death. Even if they survive, as many as 15% to 20% of these women experience long-
term sequelae of PID, such as ectopic pregnancy, tubo-ovarian abscess, infertility, 
dyspareunia and chronic pelvic pain. The best treatments for PID are interventions that lead 
to prevention and early detection136.   
4.3 Intrauterine devices (IUD)  
Intrauterine contraceptive devices (IUDs) are highly effective, long-term methods of 
contraception. It is also one of the most cost-effective method available, providing long-term 
protection137. Most modern IUDs are medicated; they contain either copper or a progestin to 
enhance the contraceptive action of the device. The total number of current IUD users is 
estimated at over 150 million women worldwide138. Infection risk is a relative 
contraindication to fitting any woman with an IUD, it is only present for a few weeks after 
insertion and probably arises from an undiagnosed cervical infection at the time of insertion.  
Although evidence of a direct association between IUD use and PID is scarce, concerns 
about PID related to IUDs use has limited their use throughout the world. On the other 
hand, bacteriologic cultures of removed IUDs have shown that the bacterial flora of the 
removed IUDs consisted of common aerobic and anaerobic microorganisms that do not 
account for PID139. In a study with 200 subjects, the most common bacteria identified from 
removed IUDs were Staphylococcus coagulase negative, Esherichia coli, and Enterococcus 
faecalis139. The authors concluded that culture of the removed IUDs and therapeutic 
management of women with positive cultures are not recommended when women are 
asymptomatic for PID139. A systematic review reported the risks of PID with insertion of an 
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IUD in the presence of existing infection. With IUD insertion in the presence of Chlamydia 
infection or gonorrhoea, subsequent PID rates were 0-5%, compared to insertion in the 
absence of infection (0-2%)140. Although trial results do not indicate the need to screen for 
and treat sexually transmitted diseases before inserting and IUD141, it is rationale to suggest 
that the insertion of an IUD is indicated only in women with negative vaginal cultures 
(Table 4)142.  
 
NOT contraindicated Contraindicated 
Increased risk of STI or HIV Current PID 
Continuation after STI diagnosed Current purulent cervicitis 
Past PID Chlamydial infection 
Past ectopic pregnancy Gonorrheal infection 
HIV or AIDS Pelvic tuberculosis 
Diabetes Puerperal sepsis 
Menorrhagia Septic abortion 
Fibroids  
Age<20  
STI: sexually transmitted infection; PID: pelvic inflammatory disease 
Table 4. Conditions in which intrauterine contraception is and is NOT contraindicated 
(WHO, 2004) 
In cases of vaginal infection, it is possible that the insertion of an IUD carries bacteria into 
the uterus and traumatizing the endometrium causes several infections. Cases of vaginitis143, 
transfer of actinomyces into the uterine cavity144, PID145, and even toxic shock syndrome146, 
and sepsis147, have occasionally been reported. Three cases of streptococcal toxic shock 
syndrome following insertion of an IUD have been reported, recently146,148,149. This pathogen 
is not normally found in the vaginal flora or after an intrauterine device is inserted150. 
However, an association between the use of IUD and the risk for infection and sepsis does 
not exist. Conditions which represent an unacceptable health risk if an IUD is inserted are: 
current PID, current purulent cervicitis, chlamydial or gonorrheal infection, as well as, 
pelvic tuberculosis, puerperal sepsis, and septic abortion (Table 4)151.  
4.4 Gynecologic cancer 
Sepsis and septic shock are not directly associated with gynecologic cancer. The female 
cancer patient is a vulnerable patient. Usually after having undergone a difficult operation, 
followed up by several chemotherapy cycles, has reduced defenses against infection due to: 
a) reduced antibody formation; b) deficient cell immunity; c) reduced or abnormal 
granulocytes; d) damaged mucocutaneous barriers, such as, ulceration of the oropharynx 
due to methotrexate toxicity; e) obstruction of biliary and urinary tracts. Thus, 
myelosuppression may also give rise to an acute septic problem associated with 
neutropenia, granulocytopenia. In these patients, any infection may have an acute form 
leading to rapid septicemia and severe shock developing rapidly. 
The frequency of patients with gynecologic cancer and septic shock is not seen very often. In 
a recent study, the mortality rate was 33% (of 6 reported cases, 2 died)152. Sepsis can occur 
independently of the optimal management of cancer. Among 74 women with gynecologic 
cancer, there was one death due to the development of septic shock in a patient with 
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optimal cytoreductive operation153. Toxic shock syndrome has been developed in a patient 
with a metastatic cervical cancer154. In advanced operations (pelvic exenterosis) where a 
colostomy has been performed, there is also a possibility of sepsis due to spillage of stool 
upon maturing the colostomy155. When operations for gynecologic cancer involve the 
intestine there is increased possibility for sepsis. In a series of 113 patients three died due to 
sepsis post-operatively156. Early diagnosis, careful monitoring, prompt removal of septic 
foci, and appropriate antibiotic and supportive treatment are the most important factors 
influencing prognosis in these patients.  
5. Conclusion 
Sepsis and septic shock are not specifically correlated with obstetrics or gynecologic 
conditions. Risk factors that may predispose an Ob/Gyn patient to infectious agents are 
essentially the same risk factors that place any patient in harm’s way. In Obstetrics, a prior 
history of peripatum infection, prolonged rupture of membranes, or genitourinary 
instrumentation associated with cardiovascular instability and fever should raise the 
possibility of septic shock.  
Patients with obstetrics or gynecologic problems are not different in the management of 
septic shock with other patients that sepsis results from other organs. Management of a 
patient with septic shock requires simultaneous administration of agents to reverse 
the pathophysiologic processes set in motion. It is important to treat patients with sepsis 
early and vigorously. Volume expansion and correction of hypovolemia are critical. 
Understanding the pathways, mediators, feedback loops and interactions involved in the 
pathogenesis of sepsis and organ failure has advanced profoundly, giving us the 
opportunity to treat sepsis-related multiple organ failure, and therefore, improve both 
survival rates and quality of life of women patients. 
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